Delmer Dee Raibourn III
@Avidity Partners Management Lp
Latest period2024 - Q3ReportedManaged Assets$1.96BTotal holdings81
Assets growth rate-16.7%Assets growth rate (2-Q avg)-20.41%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Avidity Partners Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 81 positions.
Assets under management
The assets under management (AUM) of Avidity Partners Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.96B in assets, with a quarterly growth rate of -16.7% and a 2-quarter average growth rate of -20.41%. The portfolio is managed by Delmer Dee Raibourn III, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ILMNIllumina Inc
| 1.95% | $38.08M 292,000 shares@ $130.41 avg price | Decreased -38.91% |
ARVNArvinas Inc
| 1.89% | $36.871M 1.497M shares@ $24.63 avg price | Decreased -49.89% |
AVTRAvantor Inc
| 1.63% | $31.949M 1.235M shares@ $25.87 avg price | Decreased -59.98% |
BPMCBlueprint Medicines Corp
| 1.49% | $29.137M 315,000 shares@ $92.5 avg price | Decreased -17.75% |
SGRYSurgery Partners Inc
| 1.37% | $26.662M 827,000 shares@ $32.24 avg price | Decreased -36.69% |
AXSMAxsome Therapeutics Inc
| 1.36% | $26.611M 296,100 shares@ $89.87 avg price | Decreased -21.25% |
DHRDanaher Corporation
| 1.35% | $26.412M 95,000 shares@ $278.02 avg price | Decreased -36.66% |
JANXJanux Therapeutics Inc
| 1.31% | $25.532M 562,000 shares@ $45.43 avg price | Decreased -33.11% |
ARGXArgenx Se
| 1.06% | $20.707M 38,200 shares@ $542.08 avg price | Decreased -36.85% |
INCYIncyte Corp
| 1.04% | $20.366M 308,110 shares@ $66.1 avg price | Decreased -41.75% |